Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart.
Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.
Eligibility criteria
Qualifiers
Men and women able to give informed consent and complete a 2 page questionnaire
Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD)
Biological parent of individual with SCAD
Relative with fibromuscular dysplasia, arterial aneurysm, or arterial dissection
Disqualifiers
Lack of confirmation of SCAD diagnosis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov